| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0005 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |